241 related articles for article (PubMed ID: 11811958)
1. A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis.
Noonan DJ; Lou D; Griffith N; Vanaman TC
Arch Biochem Biophys; 2002 Feb; 398(1):132-40. PubMed ID: 11811958
[TBL] [Abstract][Full Text] [Related]
2. Tuberin nuclear localization can be regulated by phosphorylation of its carboxyl terminus.
York B; Lou D; Noonan DJ
Mol Cancer Res; 2006 Nov; 4(11):885-97. PubMed ID: 17114346
[TBL] [Abstract][Full Text] [Related]
3. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
5. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.
Ali M; Girimaji SC; Markandaya M; Shukla AK; Sacchidanand S; Kumar A
Acta Neurol Scand; 2005 Jan; 111(1):54-63. PubMed ID: 15595939
[TBL] [Abstract][Full Text] [Related]
6. Proteins interacting with the tuberous sclerosis gene products.
Rosner M; Freilinger A; Hengstschläger M
Amino Acids; 2004 Oct; 27(2):119-28. PubMed ID: 15351877
[TBL] [Abstract][Full Text] [Related]
7. Cloning, developmental expression, and evidence for alternative splicing of the murine tuberous sclerosis (TSC2) gene product.
Kim KK; Pajak L; Wang H; Field LJ
Cell Mol Biol Res; 1995; 41(6):515-26. PubMed ID: 8777431
[TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
Astrinidis A; Henske EP
Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
[TBL] [Abstract][Full Text] [Related]
9. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients.
Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM
Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698
[TBL] [Abstract][Full Text] [Related]
10. Novel TSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutation.
Feng JH; Yamamoto T; Nanba E; Ninomiya H; Oka A; Ohno K
Hum Mutat; 2004 Apr; 23(4):397. PubMed ID: 15024740
[TBL] [Abstract][Full Text] [Related]
11. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
Tsuchiya H; Orimoto K; Kobayashi K; Hino O
Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946
[TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
[TBL] [Abstract][Full Text] [Related]
13. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
[TBL] [Abstract][Full Text] [Related]
14. Metastasis of benign tumor cells in tuberous sclerosis complex.
Henske EP
Genes Chromosomes Cancer; 2003 Dec; 38(4):376-81. PubMed ID: 14566858
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues.
Xu L; Sterner C; Maheshwar MM; Wilson PJ; Nellist M; Short PM; Haines JL; Sampson JR; Ramesh V
Genomics; 1995 Jun; 27(3):475-80. PubMed ID: 7558029
[TBL] [Abstract][Full Text] [Related]
16. Deletion of 11 amino acids in tuberin associated with severe tuberous sclerosis phenotypes: evidence for a new essential domain in the first third of the protein.
Jobert S; Bragado-Nilsson E; Samolyk D; Pedespan JM; Marchal C; Reichert S; Mallet J; Pitiot G
Eur J Hum Genet; 1997; 5(5):280-7. PubMed ID: 9412784
[TBL] [Abstract][Full Text] [Related]
17. The tuberous sclerosis 2 gene product can localize to nuclei in a phosphorylation-dependent manner.
Lou D; Griffith N; Noonan DJ
Mol Cell Biol Res Commun; 2001 Nov; 4(6):374-80. PubMed ID: 11703097
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.
Strizheva GD; Carsillo T; Kruger WD; Sullivan EJ; Ryu JH; Henske EP
Am J Respir Crit Care Med; 2001 Jan; 163(1):253-8. PubMed ID: 11208653
[TBL] [Abstract][Full Text] [Related]
19. Ets protein Elf-1 bidirectionally suppresses transcriptional activities of the tumor suppressor Tsc2 gene and the repair-related Nth1 gene.
Honda S; Kobayashi T; Kajino K; Urakami S; Igawa M; Hino O
Mol Carcinog; 2003 Jul; 37(3):122-9. PubMed ID: 12884363
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.
Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M
Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
